Join the Rare Disease Summit session “Harnessing the Power of Limited Data – Turning Rare Disease Information into Commercial Insights” on March 17, from 2:00–2:45 p.m. This live event is designed for rare disease leaders who need to make confident commercial decisions despite small, fragmented data sets.
In just 45 minutes, you will explore innovative data sources and partnerships that can help you better identify and understand rare disease patients, even when traditional datasets fall short. Learn practical techniques for processing, linking, and activating disparate data streams in a commercial setting to inform market sizing, patient identification, and strategic planning.
The session will also cover key legal and ethical considerations, including the differences between de-identified and non-de-identified patient data, so you can unlock insights while safeguarding patient privacy and complying with evolving regulations. You will walk away with a clearer view of how to use limited data responsibly to shape access strategies, field deployment, and overall commercial approach in rare disease.
Hear directly from experts working at the intersection of data and rare disease: Hillary Gretton, Director of Data Strategy at Claritas Rx, and David Du, Senior Manager of Market Access for Rare Disease at Chiesi Group. They will share real-world perspectives, examples, and best practices you can apply immediately to your own rare disease portfolio.
Visit Claritas Rx at Booth 113
Claritas Rx will also be exhibiting at booth 113 during the ACCESS USA event. Stop by to connect with our team and see how we’re helping life sciences organizations transform complex data into actionable insights that drive better access strategies and patient outcomes. We look forward to meeting you and discussing innovative approaches to solving rare disease data challenges.
